Publications
- Contribution of registry of monoclonal gammopathies for monitoring of patients with MGUS and multiple myeloma - current state2011 | Faculty of Medicine in Hradec Králové
- Prognosis of high-risk group of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)2011 | Faculty of Medicine in Hradec Králové
- Results of primary analysis from the RMG registry - importance of free short chains in the MGUS prognosis and evaluation of complete remission of MM2011 | Faculty of Medicine in Hradec Králové
- Monoclonal gammopathy of undeterminated significance: introduction and current clinical issues2011 | Faculty of Medicine in Hradec Králové
- The MGUS project - analysis of data of 616 patients from the RMG registry2010 | Faculty of Medicine in Hradec Králové
- MGUS 2010 - research project focused on identification of high-risk precancerosis +12009 | Faculty of Medicine in Hradec Králové
- Monoclonal gammopathies of unknown significance +12008 | Faculty of Medicine in Hradec Králové
- Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Central Library of Charles University
- Standardized 18F-FDG PET/CT in patients with myeloma: joint recommendation of Czech Myeloma Group and Czech Society of Nuclear Medicine2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Standardization of PET/CT in patients with multiple myeloma – Joint recommendation of The Czech Myeloma Group and The Czech Society of Nuclear Medicine2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
Loading network view...